CompoAtlas

Zinc Oxide 25%

Natural health product licensed in Canada

Licence holder
BIOVANTEK
NPN or DIN-HM
80067335
Status
Inactive licence
Licence date
3 March 2016
Revision date
17 March 2021
Form
Onguent
Route of administration
Topique
Application type
Officinale

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the source
Oxyde de zinc

Source : Oxyde de zinc

25 %

Non-medicinal ingredients

Lanoline, Pétrolatum blanc, Amidon de maïs

PopulationAgeQuantity per servingFrequency
Adultes et enfantsNot specifiedNot specifiedNot specified

Uses authorised in Canada

Aide à prévenir l'érythème fessier. Protége la peau lésée (ou légèrement irritée) en raison d'un érythème fessier. Aide à protéger contre la moiteur qui provoque l'érythème fessier. Aide à soulager temporairement les irritations mineures cutanées provoquées par l'érythème fessier.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80067335

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2021. Photograph the packaging to check whether it has changed. Photograph the packaging

List recorded in 2021. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line